Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that antiandrogenic drugs like cyproterone acetate and spironolactone are effective but not permanent treatments for skin-related androgenization in women.

Norethisterone (jenapharm) therapy is effective for endometrial cancer.

Cytokines and neuropeptides are key in controlling androgen levels, affecting skin and hair conditions.

A woman's hair loss was linked to a rare hormone-secreting ovarian tumor, treated with surgery and hair loss medication.

Removing a testosterone-producing tumor cured a woman's sleep apnea and other symptoms.

Early-onset baldness is linked to a higher risk of aggressive prostate cancer in African-American men, especially before age 60.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

Ficus carica leaf extract may help treat skin disorders by reducing inflammation and androgen effects in skin cells.

The conclusion is that there might be a link between certain types of baldness and prostate cancer, which could be due to shared hormonal pathways.

Excessive hair growth in women can be harmless or signal serious health issues, and treatment often includes medication and hair removal, with noticeable results after 3-6 months.

The document concludes that managing female hyperandrogenism requires a combination of identifying the cause, lifestyle changes, medication, and cosmetic treatments.

New treatments for cancer and skin disorders show promise in disrupting harmful cell interactions and promoting hair growth.

Prostate cancer risk is not linked to blood testosterone levels.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

CEC levels may be a useful marker for predicting prostate cancer progression.

The conclusion suggests a new treatment for infantile hemangiomas and a potential target for hair loss treatment.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Hormones affect prostate health and disease, with certain hormone imbalances linked to prostate cancer and benign prostatic hyperplasia.

Spironolactone, a heart and liver drug, has new uses including cancer treatment, viral infection prevention, and skin condition improvement.

Hirsutism requires identifying the cause to choose the right treatment, which may include medications like oral contraceptives or dexamethasone.

High prolactin levels can cause skin and hair symptoms similar to those caused by hormone imbalances.

CT scans can find serious prostate cancer even when PSA levels are low.

New treatments may restore cancer-blocking proteins, slow prostate cancer, identify drug targets, and potentially regrow hair.

The document concludes that accurate diagnosis and treatment are crucial in dermatology, and it presents various findings on skin conditions and treatments.

Female hyperandrogenism is a condition caused by too much male hormones, leading to skin issues and ovulation problems, often due to Polycystic Ovary Syndrome, and is treated based on individual symptoms.

Most women with excess hair growth need only a clinical evaluation and minimal tests unless they show signs of virilism.

Testosterone metabolism in balding scalp cells may not be the main cause of hair loss.

More research is needed to understand how testosterone is maintained in adult males.

A 21-year-old male with a rare genetic disorder experienced sudden hair loss and high DHEAS levels, likely due to a condition similar to PCOS, usually seen in women.

The case showed the need for quick investigation of virilization in women and how emotional health is linked to physical health.